Deutsche Bank’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.7M Sell
92,890
-2,090
-2% -$218K ﹤0.01% 1002
2025
Q1
$11.1M Sell
94,980
-25,567
-21% -$2.98M ﹤0.01% 979
2024
Q4
$10.2M Buy
120,547
+32,789
+37% +$2.77M ﹤0.01% 1015
2024
Q3
$7.89M Buy
87,758
+7,555
+9% +$679K ﹤0.01% 1094
2024
Q2
$6.46M Sell
80,203
-2,921
-4% -$235K ﹤0.01% 1145
2024
Q1
$6.63M Buy
83,124
+3,272
+4% +$261K ﹤0.01% 1146
2023
Q4
$6.36M Buy
79,852
+19,806
+33% +$1.58M ﹤0.01% 1154
2023
Q3
$4.2M Buy
60,046
+2,407
+4% +$168K ﹤0.01% 1081
2023
Q2
$4.14M Sell
57,639
-7,220
-11% -$519K ﹤0.01% 1306
2023
Q1
$4M Buy
64,859
+16,815
+35% +$1.04M ﹤0.01% 1324
2022
Q4
$3.71M Buy
48,044
+2,623
+6% +$202K ﹤0.01% 1345
2022
Q3
$2.03M Sell
45,421
-892
-2% -$39.8K ﹤0.01% 1610
2022
Q2
$1.77M Sell
46,313
-2,216
-5% -$84.9K ﹤0.01% 1837
2022
Q1
$2.01M Sell
48,529
-1,476
-3% -$61.1K ﹤0.01% 1885
2021
Q4
$1.89M Sell
50,005
-30,222
-38% -$1.14M ﹤0.01% 2024
2021
Q3
$2.65M Buy
80,227
+34,029
+74% +$1.12M ﹤0.01% 1891
2021
Q2
$3.12M Sell
46,198
-10,852
-19% -$732K ﹤0.01% 1842
2021
Q1
$3.23M Buy
57,050
+3,865
+7% +$219K ﹤0.01% 1836
2020
Q4
$4.33M Buy
53,185
+6,478
+14% +$528K ﹤0.01% 1427
2020
Q3
$3.33M Buy
46,707
+766
+2% +$54.6K ﹤0.01% 1444
2020
Q2
$3.78M Sell
45,941
-992
-2% -$81.6K ﹤0.01% 1441
2020
Q1
$2.76M Buy
46,933
+10,401
+28% +$612K ﹤0.01% 1531
2019
Q4
$3.78M Buy
36,532
+29,108
+392% +$3.01M ﹤0.01% 1610
2019
Q3
$148K Sell
7,424
-169,688
-96% -$3.38M ﹤0.01% 3306
2019
Q2
$4.56M Buy
+177,112
New +$4.56M ﹤0.01% 1869
2018
Q2
Sell
-334
Closed 4889
2018
Q1
$0 Sell
334
-7,300
-96% ﹤0.01% 4848
2017
Q4
$42K Buy
7,634
+7,600
+22,353% +$41.8K ﹤0.01% 4158
2017
Q3
$0 Sell
34
-17,397
-100% ﹤0.01% 4348
2017
Q2
$95K Buy
17,431
+11,568
+197% +$63K ﹤0.01% 4000
2017
Q1
$22K Sell
5,863
-1,245
-18% -$4.67K ﹤0.01% 4135
2016
Q4
$47K Buy
7,108
+5,279
+289% +$34.9K ﹤0.01% 4084
2016
Q3
$14K Buy
1,829
+91
+5% +$697 ﹤0.01% 4233
2016
Q2
$12K Sell
1,738
-2,015
-54% -$13.9K ﹤0.01% 4515
2016
Q1
$32K Buy
+3,753
New +$32K ﹤0.01% 4199